"CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, World Biggest Manufacturer
CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, , EE 99.9%, CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, ,HPLC more than 99.5%, Impurity less than 0.1%, Water less than 0.1%, stock keep 10-50kg.
CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, stable novel crystalline or amorphous form both we have, CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, no any IP problem. CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, DMF filling, free sample of CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, .
EOS Med Chem have already carried out CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, Intermeidates list, most from GMP plant:
Cefcaneldaloxate, CAS 92602-21-6;97275-40-6(free) Intermediate, 88739-47-3, stock 5.8kg, assay 98.3%, White powder.
CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, HNMR, MASS, COA, MSDS we have.
CAS 92602-21-6;97275-40-6(free)，Cefcaneldaloxate, , free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com"
